MET.EXTRA GROUP SPA (MET.MI) Fundamental Analysis & Valuation

BIT:MET • IT0005481855

Current stock price

2 EUR
+0.15 (+8.11%)
Last:

This MET.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MET.MI Profitability Analysis

1.1 Basic Checks

  • In the past year MET was profitable.
  • MET had a positive operating cash flow in the past year.
  • MET had positive earnings in 4 of the past 5 years.
  • In multiple years MET reported negative operating cash flow during the last 5 years.
MET.MI Yearly Net Income VS EBIT VS OCF VS FCFMET.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

1.2 Ratios

  • MET's Return On Assets of 5.90% is amongst the best of the industry. MET outperforms 81.03% of its industry peers.
  • MET's Return On Equity of 9.26% is fine compared to the rest of the industry. MET outperforms 60.34% of its industry peers.
  • The Return On Invested Capital of MET (9.82%) is better than 77.59% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MET is in line with the industry average of 10.88%.
Industry RankSector Rank
ROA 5.9%
ROE 9.26%
ROIC 9.82%
ROA(3y)6.31%
ROA(5y)2.56%
ROE(3y)9.8%
ROE(5y)1.51%
ROIC(3y)10.32%
ROIC(5y)N/A
MET.MI Yearly ROA, ROE, ROICMET.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

  • MET has a Profit Margin (5.75%) which is in line with its industry peers.
  • The Operating Margin of MET (10.30%) is comparable to the rest of the industry.
  • MET's Gross Margin of 16.59% is on the low side compared to the rest of the industry. MET is outperformed by 62.07% of its industry peers.
  • MET's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.3%
PM (TTM) 5.75%
GM 16.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.46%
GM growth 5YN/A
MET.MI Yearly Profit, Operating, Gross MarginsMET.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MET.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MET is still creating some value.
  • The number of shares outstanding for MET remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for MET has been reduced compared to 5 years ago.
  • MET has a better debt/assets ratio than last year.
MET.MI Yearly Shares OutstandingMET.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MET.MI Yearly Total Debt VS Total AssetsMET.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of 1.57, we must say that MET is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.57, MET is in line with its industry, outperforming 58.62% of the companies in the same industry.
  • MET has a debt to FCF ratio of 72.26. This is a negative value and a sign of low solvency as MET would need 72.26 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 72.26, MET is not doing good in the industry: 63.79% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.15 indicates that MET is not too dependend on debt financing.
  • MET's Debt to Equity ratio of 0.15 is fine compared to the rest of the industry. MET outperforms 70.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 72.26
Altman-Z 1.57
ROIC/WACC1.65
WACC5.94%
MET.MI Yearly LT Debt VS Equity VS FCFMET.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • MET has a Current Ratio of 1.87. This is a normal value and indicates that MET is financially healthy and should not expect problems in meeting its short term obligations.
  • MET has a Current ratio of 1.87. This is in the better half of the industry: MET outperforms 70.69% of its industry peers.
  • A Quick Ratio of 1.48 indicates that MET should not have too much problems paying its short term obligations.
  • MET has a Quick ratio of 1.48. This is in the better half of the industry: MET outperforms 63.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.48
MET.MI Yearly Current Assets VS Current LiabilitesMET.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MET.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 46.44% over the past year.
  • MET shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.81%.
  • MET shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 126.36% yearly.
EPS 1Y (TTM)46.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.48%
Revenue 1Y (TTM)30.81%
Revenue growth 3Y297.58%
Revenue growth 5Y126.36%
Sales Q2Q%49.19%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MET.MI Yearly Revenue VS EstimatesMET.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

Find the best growth stocksShow best growing peers

4

4. MET.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 2.86 indicates a rather cheap valuation of MET.
  • MET's Price/Earnings ratio is rather cheap when compared to the industry. MET is cheaper than 91.38% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.54. MET is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.86
Fwd PE N/A
MET.MI Price Earnings VS Forward Price EarningsMET.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MET indicates a rather cheap valuation: MET is cheaper than 87.93% of the companies listed in the same industry.
  • 72.41% of the companies in the same industry are more expensive than MET, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.59
EV/EBITDA 1.25
MET.MI Per share dataMET.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MET.MI Dividend Analysis

5.1 Amount

  • MET does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MET.MI Fundamentals: All Metrics, Ratios and Statistics

MET.EXTRA GROUP SPA

BIT:MET (3/19/2026, 7:00:00 PM)

2

+0.15 (+8.11%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.3%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.16M
Revenue(TTM)50.98M
Net Income(TTM)2.93M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.86
Fwd PE N/A
P/S 0.02
P/FCF 9.59
P/OCF 0.25
P/B 0.04
P/tB 0.07
EV/EBITDA 1.25
EPS(TTM)0.7
EY35%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.21
FCFY10.43%
OCF(TTM)8.06
OCFY403.19%
SpS87.9
BVpS54.58
TBVpS27.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number29.32
Profitability
Industry RankSector Rank
ROA 5.9%
ROE 9.26%
ROCE 14.24%
ROIC 9.82%
ROICexc 10.31%
ROICexgc 18.81%
OM 10.3%
PM (TTM) 5.75%
GM 16.59%
FCFM 0.24%
ROA(3y)6.31%
ROA(5y)2.56%
ROE(3y)9.8%
ROE(5y)1.51%
ROIC(3y)10.32%
ROIC(5y)N/A
ROICexc(3y)10.81%
ROICexc(5y)N/A
ROICexgc(3y)24.44%
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.46%
GM growth 5YN/A
F-Score6
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 72.26
Debt/EBITDA 0.72
Cap/Depr 354.55%
Cap/Sales 8.94%
Interest Coverage 250
Cash Conversion 71.55%
Profit Quality 4.13%
Current Ratio 1.87
Quick Ratio 1.48
Altman-Z 1.57
F-Score6
WACC5.94%
ROIC/WACC1.65
Cap/Depr(3y)150.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.95%
Cap/Sales(5y)2.42%
Profit Quality(3y)203.21%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.81%
Revenue growth 3Y297.58%
Revenue growth 5Y126.36%
Sales Q2Q%49.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-40.94%
OCF growth 3YN/A
OCF growth 5YN/A

MET.EXTRA GROUP SPA / MET.MI Fundamental Analysis FAQ

What is the fundamental rating for MET stock?

ChartMill assigns a fundamental rating of 4 / 10 to MET.MI.


What is the valuation status for MET stock?

ChartMill assigns a valuation rating of 4 / 10 to MET.EXTRA GROUP SPA (MET.MI). This can be considered as Fairly Valued.


What is the profitability of MET stock?

MET.EXTRA GROUP SPA (MET.MI) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for MET stock?

The Price/Earnings (PE) ratio for MET.EXTRA GROUP SPA (MET.MI) is 2.86 and the Price/Book (PB) ratio is 0.04.


What is the financial health of MET.EXTRA GROUP SPA (MET.MI) stock?

The financial health rating of MET.EXTRA GROUP SPA (MET.MI) is 4 / 10.